Présentation de l'entreprise
Flotek Industries, Inc. operates as a specialized chemical and data analytics enterprise with a geographic footprint spanning the United States, the United Arab Emirates, and various international markets. The company generates revenue through two distinct operational segments: Chemistry Technologies (CT) and Data Analytics (DA), where the CT segment specifically delivers proprietary chemistry solutions to its client base. Within the broader financial landscape, Flotek is classified under the Energy sector, specifically within the Oil & Gas Equipment & Services industry, positioning it as a critical supplier to the upstream and midstream energy infrastructure. As of the latest reporting period, the company possesses a market capitalization of $569.75M and recorded annual revenue of $237.26M, while employing a workforce of 158 individuals. These valuation and revenue figures indicate that Flotek holds a mid-cap status, suggesting it is a significant yet not dominant player in the niche of industrial chemical services, with its scale reflecting a balance between established operational reach and the agility typical of smaller, specialized firms.
Santé financière
The company reported a total revenue of $237.26M over the trailing twelve months, resulting in a net income of $30.53M and an EBITDA of $29.96M. The substantial gap between the revenue figure and the net income reveals a cost structure where operating expenses, including cost of goods sold and administrative costs, consume a significant portion of gross revenue before reaching the bottom line. Flotek generated free cash flow of $17.07M, a metric that signifies the company retains sufficient liquid cash after capital expenditures to fund operations, service debt, or pursue strategic initiatives without relying heavily on external financing. The company maintains a cash balance of $5.73M against total debt of $51.58M, resulting in a debt-to-equity ratio of 45.62, which indicates a moderately leveraged balance sheet rather than a conservative, cash-heavy position. Despite the leverage, the current ratio stands at 1.80, demonstrating that the company holds 1.80 times more current assets than current liabilities and thus maintains adequate short-term liquidity to meet its obligations as they come due. Management effectiveness is further evidenced by a return on equity of 26.9% and a return on assets of 9.0%, metrics that suggest the firm generates high returns relative to shareholder capital invested while utilizing its asset base efficiently to produce earnings.
Évaluation de la valorisation
Valuation multiples for Flotek reflect a trailing P/E ratio of 18.75 and a forward P/E of 16.94, implying that the market expects earnings growth in the future that would justify a lower multiple compared to historical performance. The price-to-book ratio is recorded at 4.19, indicating that the market values the company at a significant premium over its net book value, likely due to the intangible value of its proprietary chemistries and data analytics capabilities. Alternative valuation metrics show a price-to-sales ratio of 2.40 and an EV/EBITDA of 20.52, suggesting that investors are willing to pay a premium for sales and earnings relative to the industry average, though the high EV/EBITDA must be contextualized against the company's debt levels. The stock's price volatility is framed by a 52-week high of $20.41 and a 52-week low of $6.14, illustrating a wide trading range where the current price sits significantly below the recent peak, reflecting potential market sentiment shifts or sector-specific headwinds. The beta value of 1.46 indicates that Flotek's share price is approximately 46% more volatile than the broader market index, meaning the stock tends to amplify market movements, presenting both higher risk and potential for accelerated returns during trending market conditions.
Growth & Income
The company experienced a revenue growth rate of 33.0% year-over-year, while earnings growth declined by 48.4% over the same period, indicating that earnings are growing significantly slower than revenue, likely due to margin compression or one-time costs affecting the bottom line. As a non-dividend payer, Flotek reports a dividend yield of N/A and a payout ratio of 0.0%, confirming that the company retains all its earnings to reinvest into organic growth, technology development, or debt reduction rather than distributing cash to shareholders. This retention strategy suggests management prioritizes capital allocation toward expanding the Chemistry Technologies or Data Analytics segments to capture future value rather than providing immediate income to investors. Overall, Flotek presents a growth-oriented profile characterized by strong top-line expansion offset by temporary earnings contraction, with no reliance on dividend income and a capital structure that balances leverage against operational cash generation.